Aggressive B-Cell Non-Hodgkin Lymphoma
4 clinical trials · Condition
◉ Watch Aggressive B-Cell Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma (NCT05025800) | M.D. Anderson Cancer Center | 2021-10-13 |
| A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-Lymphoma (NCT05840289) | University Hospital, Geneva | 2020-08-24 |
Track Aggressive B-Cell Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.